New LEQEMBI Companion™ program launched to expand helpful resources for patients throughout the treatment journey, including Nurse Educators who ...

The tennis star looked happy and slender in the skimpy baby blue lace-trimmed outfit that made the most of her slender legs.

Treatment with Sanofi's frexalimab was seen in a study to safely maintain disease control over 2.5 years in adults with ...

Get going with our next company presenter at the BofA Healthcare Conference here in London. Pleased to be introducing Teva Pharmaceuticals and CEO, Richard Francis. My name is Jason Gerberry. I'm one ...

Researchers sought to determine whether subcutaneous isatuximab would be an effective treatment for patients with RRMM.

A subcutaneous injection that can administer an immunotherapy in 1–2 minutes using domestic technology has been developed and approved in the United States. Immunotherapies are usually given ...

The first immune checkpoint inhibitor that can be administered via subcutaneous injection in just 1 to 2 minutes has emerged. Alteogen announced on the 20th that its partner, U.S. Merck, MSD, had ...

HealthDay News — The US Food and Drug Administration (FDA) has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ...

MAINEVILLE, OH − How many golfers can say they made a birdie in a professional tournament in their own backyard? In the second round of the Kroger Queen City Championship Sept. 12, Mary Liu pulled off ...

Merck (NYSE:MRK) said that the FDA has cleared Keytruda Qlex, a new subcutaneous version of its blockbuster cancer drug, offering a faster alternative to IV infusion, a company spokesperson confirmed ...

Dr. Rubin highlights a new subcutaneous induction for UC, stressing convenience, access, and sustained remission.